Phase 3
N=240
Intervention to Improve Driving Practices Among High-Risk Teen Drivers
Drive · Recidivism · Communication · Feedback, Psychological
Bottom Line
View on ClinicalTrials.gov: NCT04317664 ↗Enrolled (actual)
240
Serious AEs
0.0%
Results posted
Feb 2026
Primary outcome: Primary: Risky Driving Events — 101.3; 106.2; 77.7 Average number of events per 1000 miles
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 3
- Interventions
- In-vehicle device (Combination_product); Parent Communication (Behavioral)
- Age
- Pediatric · 16+ yrs
- Sex
- All
- Sponsor
- Ginger Yang
- Primary completion
- Dec 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Risky Driving Events |
101.3; 106.2; 77.7 | — |
| PRIMARY Unsafe Behaviors |
0.19; 0.19; 0.16; 0.09; 0.12; 0.07 | — |
| SECONDARY Recidivism |
— | — |
| SECONDARY Parent-Teen Communication |
— | — |
Summary
The purpose of this study is to test the effects of an in-vehicle driving feedback technology, with and without parent communication training, on risky driving events, unsafe driving behaviors, and subsequent traffic violations among teens who have recently received a moving traffic violation.
Eligibility Criteria
Inclusion Criteria
- Age 16-17 years at time of violation
- Convicted of a moving violation
- Possess a valid intermediate driver's license issued by the state of Ohio, with proof of car insurance
- Access to a vehicle with an On-board Diagnostics II system port (i.e. cars made after 1996) in which he/she is the primary driver
- Smartphone with Bluetooth capabilities
- At least one legal guardian
Exclusion Criteria
- Unable to drive due to injury, license suspension, or car damage
- Vehicle already has an in-vehicle driving feedback system installed
- Extremely low average weekly drive time (e.g. <1 hour per week)
- Currently enrolled in another driving-related study
- War of the State
- Non-English speaking parent
- Adults unable to consent
- Pregnant women
- Prisoners
Data sourced from ClinicalTrials.gov (NCT04317664). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.